000 | 00790 a2200229 4500 | ||
---|---|---|---|
005 | 20250513081324.0 | ||
264 | 0 | _c19930506 | |
008 | 199305s 0 0 eng d | ||
022 | _a0041-1345 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNorman, D J | |
245 | 0 | 0 |
_aRationale for OKT3 monoclonal antibody treatment in transplant patients. _h[electronic resource] |
260 |
_bTransplantation proceedings _cApr 1993 |
||
300 |
_a1-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aGraft Rejection _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
650 | 0 | 4 |
_aMuromonab-CD3 _xadverse effects |
650 | 0 | 4 | _aTransplantation Immunology |
773 | 0 |
_tTransplantation proceedings _gvol. 25 _gno. 2 Suppl 1 _gp. 1-3 |
|
999 |
_c8464677 _d8464677 |